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REASONS FOR TRANSITION AND REVERSE TRANSITION IN 
PATIENTS WITH HEROIN DEPENDENCE 
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ABSTRACT 
Most physical complications related to opiate use are associated with the route of drug 
administration. The route of administration in opiate dependent patients may change overtime Change 
from non-parenteral to parenteral route of administration is more common than the reverse transition. 
In the current study, 17 patients of opiate dependence syndrome (DSM-IV) who had history of reverse 
transition (Shift from parenteral to inhalational route), were evaluated for the reasons for the reverse 
transition. Verbatim responses were recorded in response to open-ended questions and a semi-
structured questionnaire was also used. All the patients gave health-related reasons for this reverse 
transition and reported knowledge of health hazards of injecting route as one of the reasons for it. 
Other reasons cited by subjects for this transition were occurrence of physical complications due to 
drug use in peers and patients themselves; drug related death of peers, knowledge of risk of HIV/ 
AIDS and difficulties in getting a vein. The study emphasizes the need to educate the patients about 
the health hazards of parenteral route. 
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The route of administration is an important 
characteristic related to abuse of drugs (Strang 
et ai. (1997). Many complications including 
increased risk of HIV infection are associated with 
the method of drug administration. The route of 
administration changes over time in patients of 
opiate dependence syndrome. Various studies 
in the past reported that 29-50% of opiate (heroin) 
dependent patients change their route of 
administration (Griffiths etal, 1992; De La Funente 
et al., 1997; Swift, et al., 1999). The change of 
route of administration from inhalational to 
parenteral route is more common (Griffiths et al., 
1994; Swift, et al., 1999). In a study (Strang et 
al., 1997), it was twice as common as shift from 
parenteral route to non-parenteral route which is 
known as reverse transition and occurs in 3-25% 
of opiate dependent patients (Griffiths et al., 1992; 
Swift, etal., 1999). 
In India, parenteral use of buprenorphine, 
mostly in combination with benzodiazepines and 
antihistaminics, has increased during last ten 
years (Ray, 1998). It has also been observed that 
may opiate dependent patients were shifting back 
from parenteral use of buprenorphine to heroin use 
by chasing (Chavan et al., 1995; Basu et al., 
2000). Heroin is usually used through inhalation 
(chasing) and the most commonly used opiate 
by injection route is buprenorphine. It is most 
commonly taken along with diazepam and 
antihistaminics. 
The present study aims to study the 
reasons for transition and reverse transition in 
route of administration in opiate dependent 
subjects. It would be worthwhile to study the 
reasons due to which patients shift to safer routes 
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of administration. Knowledge about this may 
enable us in facilitating this process. 
MATERIAL AND METHOD 
This study is a cross sectional study carried 
out over six months at De-addiction Centre, AIIMS, 
New Delhi. It included seventeen consecutive 
patients of opiate dependence syndrome 
diagnosed according to DSM-IV (APA, 1994) and 
who fulfilled the inclusion criteria. Patients 
currently using opiates predominantly by 
inhalational route (use by parenteral route < 5 days 
/month and inhalational route > 25days/month) 
during last one month or more were included. In 
the past, patients should have used opiates by 
parenteral route (use by parenteral route>25days/ 
month) for at least one month for inclusion in the 
study. 
All subjects were administered a semi-
structured questionnaire to collect information 
about demographic data, duration of drug use and 
opiate use, onset and duration of injection use 
and reasons for transition from inhalation to 
injecting route and reverse transition from injection 
to inhalational route. Patients were asked about 
reasons for transition and reverse transition by an 
open ended question to avoid getting only socially 
desirable responses and the responses were 
recorded verbatim. The questionnaire also included 
a structured question with multiple responses on 
reasons for transition and reverse transition of 
route of opiate use. Patients could give more than 
one response to these questions. The 
questionnaire was administered in the local 
language. 
RESULTS 
Seventeen subjects were taken up for the 
study. All the subjects were males with mean age 
of 33.7±4.6 years. Majority of subjects (76.3%) 
were married and more than half of the subjects 
(58.8%) had completed 8 or more years of 
schooling. As expected the opiate used by 
patients in this study through inhalational route 
was heroin, while by parenteral route was 
buprenorphine. Buprenorphine was used almost 
always along with benzodiazepines and 
antihistaminics. Mean duration of heroin use by 
inhalational route before shifting to parenteral use 
of buprenorphine was 7.5±4.4years (median 9 
years, range 0.5-14 years). Mean duration of 
regular injection use was 4.2±1.8 years. The 
duration of heroin use by inhalational route following 
reverse shift was 2.2±1.5 years (range- 6 months 
- 6 years). By virtue of our inclusion criteria, all 
patients had at least two changes in route (from 
chasing to injecting route and then again back to 
chasing). Only one patient reported change in 
route on more than two occasions; he made four 
transitions (chasing-injecting-chasing-injecting-
chasing). 
The most common reasons for transition 
from inhalational heroin use to injectable 
buprenorphine use given by patients when they 
were asked through an open ended question were-
use of injection buprenorphine as self-treatment 
of heroin dependence (41.2%) and injectable 
buprenorphine being cheaper (35,3%). While on 
preset questions easy availability (88.2%) and 
cheaper cost (82.4%) of buprenorphine injection 
were the two commonest reasons given for this 
transition. Other common reported reasons were 
that their friends were using injections (47.0%), 
to give up heroin use (41.2%), problems in 
availability of heroin (35.3%), and injection use 
giving greater high/rush (35.3%) (Table-1). 
TABLE-1 
REASONS FOR TRANSITION 
Reasons 
Easy availability 
Lower cost 
On pre set 
question n(%) 
15(88.2) 
14(82.4) 
Friends were using 8(47.0) 
injections 
As an attempt to 
leave heroin 
Problem in heroin 
availability 
Gives more kicks 
7(412) 
6(35.3) 
6(35.3) 
Gives quicker effect 2(11.8) 
On open ended 
question n(%) 
1(5.9) 
6(35.3) 
4(23.6) 
7(41.2) 
4(23.6) 
1(5.9) 
-
Most patients reported one or more health 
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related factors associated with injecting route as 
the main cause for the shift from parenteral to 
non-parenteral route, when asked about the 
reason for shifting through an open ended 
question. Occurrence of physical complications 
in them (35.3%) was the most frequently given 
response in this question. On pre-set questions, 
all the patients (100%) gave knowledge of health 
hazards of injection route as one the reasons for 
reverse transition. Other commonly given reasons 
were occurrence of physical complications due 
to drug use in peers (76.5%) and in patients 
themselves (58.8%), drug related death of peers 
(47%), fear of HIV infection (41.2%) and problem 
in finding a vein (35.3%) (Table-2). 
TABLE -2 
REASONS FOR REVERSE TRANSITION 
Reasons On pre set On open ended 
question n(%) question n{%) 
All the patients gave multiple reasons for 
the transitions on pre-set questions and one or 
two reasons on open ended questions. On pre-
set questions patients gave additional responses 
to those given on open ended questions. Patients 
reported that answers given to open ended 
questions were the main reasons for change of 
route (transition and reverse transition) while other 
reasons were contributory for transition of route. 
DISCUSSION 
Parenteral administration of drugs is 
associated with risk of HIV infection, hepatitis B, 
infections like cellulitis, abscesses and 
endocarditis (Ghodse, 1989). As part of harm 
minimization an important aspect of treatment of 
opiate dependence is encouraging patients to shift 
to safer methods of drug use if they are unable to 
stop drug use (Riley, et al.,1999). Based on our 
clinical observation of recent occurrence of reverse 
transition in route of opiate use, we were interested 
in studying the reasons for this transition. This 
could be done through a prospective or 
retrospective design. This study retrospectively 
looked into this issue through open ended 
questions and structured questions. The former 
were administered first to eliminate bias due to 
desirable responses. The structured questions 
would enable patients to recollect reasons that 
they did not give on open ended questions. 
Previous Indian studies have inquired about 
reasons related to transition from inhalational to 
parenteral route (Singh et al., 1992 and Koijam, 
et ai., 1995). Only one study also inquired about 
reasons for reverse transition although patients 
with reverse transition in their study were only eight 
in number (Koijam, etal., 1995). 
The main reasons for shift to parenteral route 
on open ended questions were related to self-
treatment of heroin dependence with injection 
buprenorphine, low cost of buprenorphine and non 
availability of heroin. Other frequently reported 
contributory reasons (from pre-set questions) were 
easy availability, use of injection by peers and 
better acute effect of injection buprenorphine. 
Previous studies (Singh et al., 1992; Koijam, et 
al., 1995; Sharma and Mattoo, 1999) found almost 
similar results. Non-availability of heroin, attempts 
to decrease heroin use and cheaper cost of 
buprenorphine were the reasons given in those 
Knowledge about 17(100) 3(17.6) 
health hazards of 
injection. 
Physical 13(76.5) 2(11.8) 
complication in peers 
Physical 10(58.8) 6(35.3) 
complication in patient 
Drug related death 8(47.0) 3(17.6) 
of peer 
Knowledge about 7(41.2) 1(5.9) 
HIV/AIDS risk 
Problem in finding 6(35.3) 3(17.6) 
a vein 
Difficulty in procuring 3(17.6) 3(17.6) 
i njectable drugs/heroin 
easily available 
As attempts towards 2(11.8) 
abstinence or recovery 
Peers have changed 1(5.9) 
to non-parenteral 
Heroin chasing 1(5.9) 
more effective 
injection is more 1(5.9) 
addictive 
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studies. 
All the patients gave health related reasons 
for reverse transition on pre-set questions and 
majority of them reported health related reasons 
as the main reasons for this transition on open 
ended questions eg.occurrence of complications 
in self or others, death of peers, knowledge of 
hazards of injection. In an earlier study (Koljam, 
et al., 1995) all the eight subjects reported 
knowledge of harmful effects and risk of HIV 
infection as one the reasons for the reverse 
transition, findings comparable to that of this 
study. Heroin being available again was given as 
one of the reasons by 6 out of 8 subjects in their 
study while only one out of 17 subjects reported 
this in the current study. A study from Spain (De 
La Fuente et al., 1997) found that 73% of heroin 
dependents who had reverse transition, reported 
that the result of the HIV test or fear of becoming 
infected with HIV were important factors for a 
reverse shift. Griffiths et al. (1994) have pointed 
out that attempts to decrease the exposure to 
injecting health risks, to moderate drug habits or 
physical consequences of injection could be 
possible reasons for injectors of heroin to shift 
back to chasing method. From findings of above 
studies including that of our study, it is apparent 
that the awareness and the occurrence of physical 
complications due to opiate use by injection route 
are among the important factors which determine 
the change of route of drug administration to a 
safer one (non-parenteral route). However, in a 
recent study from Australia (Swift, et al., 1999), 
somewhat different reasons for reverse transition 
were reported. Those were primarily situational 
factors including availability of smokeable heroin, 
being with peers or lack of opportunity for injection 
(eg. in prison) but interestingly no health related 
factors were reported as the reasons for reverse 
shift. 
All the patients gave multiple reasons for 
the transitions on pre-set questions and one or 
maximum two reasons on open ended question. 
The increased number of responses on pre-set
1 
questions as compared to response on open 
ended question could be explained by recall of 
the reasons and socially desired responses when 
presented with pre-set questions. 
This study is retrospective in design with 
the inherent limitations of any retrospective study 
including recollection bias. Since all patients gave 
health related reasons like awareness and 
occurrence of health complications related to 
parenteral route for reverse shift, it may be 
concluded that the emphasis on education of 
patients about hazards of injection route may help 
in preventing injection use or leading to change to 
non- parenteral route. 
ACKNOWLEDGEMENT 
Authors are grateful to Dr.R.Ray, Additional 
Professor, De-addiction Centre, AIIMS for his 
suggestions and guidance. 
REFERENCES 
American Psychiatric Assocation (1994) 
Diagnostic and Statistical Manual of Mental 
Disorders, IV edition (DSM-IV), Washington DC: 
American Psychiatric Association. 
Basu, D., Mattoo, S.K., Malhotra, A., 
Gupta, N. & Malhotra, R. (2000) A longitudinal 
study of male addicts attending an addiction clinic 
in India. Addiction, 95,1363-1372. 
Chavan, B.S., Tripathi, B.M. & Lai, R. 
(1995) Outcome of parenteral buprenorphine. 
Indian Journal of Psychiatry, 37(S), 24. 
De La Fuente, L., Barrio, G., Royuela, 
L., Bravo , M.J. & the Spanish Group for the 
study of the route of heroin administration 
(1997) The transition from injecting to smoking 
heroin in three Spanish cities. Addiction, 92,1749-
1763. 
Ghodse, H. (1989) Complications of drug 
abuse and their treatment. In: Drugs and addictive 
behaviour- a guide to treatment, pp 185-211, 
Oxford: Backwell Scientific Publications. 
22 REASONS FOR TRANSITION AND REVERSE TRANSITION 
Griffiths, P., Gossop, M., Powis, B.& 
Strang, J. (1992) Extent and nature of transitions 
of route among heroin addicts in treatment-
preliminary data from the Drug Transition study 
(UK Transition Report). British Journal of Addiction, 
87,485-491. 
Griffiths, P., Gossop, M., Powis, B. & 
Strang, J. (1994) Transitions in patterns of heroin 
administration: a study of heroin chasers and 
heroin injectors. Addiction, 89, 301-309. 
Koijam, S.B., Saxena, S. & Chavan, 
B.S., (1995) Factors associated with transition 
from non-injecting to injecting route in opioid 
dependent patients. MD Thesis, New Delhi: All 
India Institute of Medical Sciences. 
Ray, R., (1998) Current extent and pattern 
of drug abuse. In: South Asia Drug Demand 
Reduction Report, (Ed.) Ray, R., pp 5-36, New 
Delhi: UNDCP Regional Office for South Asia. 
Riley, D., Sawka, E., Conely, P., Hewitt, 
D., Mitlc, W., Poulin, C, Room , R., Single, E. 
, & Topp, J. (1999) Harm reduction:concepts 
and practice. A policy discussion paper. 
Substance Use and Misuse, 34, 9-24. 
Sharma, Y. & Mattoo, S.K. (1999) 
Buprenorphine abuse in India - an update. Indian 
Journal of Psychiatry, 41,152-159. 
Singh, RA, Mattoo, S.K., Malhotra, A.& 
Verma, V.K. (1992) Cases of buprenorphine abuse 
in India. Acta Psychiatrica Scandinavica, 86,46-48. 
Strang, J., Griffiths, P., Powis, Babbey, 
J. & Gossop, M. (1997) How constant is an 
individual's route of heroin administration? Data 
from treatment and non-treatment samples. Drug 
and Alcohol Dependence, 46,115-118. 
Swift, W., Maher, L., & Sunjic, S. (1999) 
Transitions between routes of heroin 
administration: a study of Caucasian and 
Indochinese heroin users in south-western sydney, 
Australia. Addiction, 94, 71-82. 
RAMESH KUMAR * MD., Senior Resident, ANJU DHAWAN, M.D., 
India Institute of Medical Sciences, New Delhi-110029 
Assistant Professor, Department of Psychiatry, All 
'Correspondence 
23 